Emerging research suggest this peptide, a dual agonist targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , could offer a significant development for obesity treatment. Preliminary https://webcastlist.com/story23037091/a-retatrutide-compound-a-innovation-in-body-regulation